Litcius/Paper detail

Phase 2 randomized clinical trial of astegolimab in patients with moderate to severe atopic dermatitis

Marcus Maurer, Dorothy Cheung, Wiebke Theess, Xiaoying Yang, Michael Dolton, Anna Guttman, David F. Choy, Ajit Dash, Michele A. Grimbaldeston, Weily Soong

2022Journal of Allergy and Clinical Immunology65 citationsDOI

Topics & Concepts

MedicineAtopic dermatitisPlaceboEczema Area and Severity IndexRandomized controlled trialInternal medicineDermatology Life Quality IndexSCORADClinical trialGastroenterologyDermatologyPathologyDiseaseAlternative medicineDermatology and Skin DiseasesIL-33, ST2, and ILC PathwaysPsoriasis: Treatment and Pathogenesis
Phase 2 randomized clinical trial of astegolimab in patients with moderate to severe atopic dermatitis | Litcius